ARTICLE | Clinical News
Introgen preclinical data
November 14, 2005 8:00 AM UTC
Researchers published in Surgery that INGN 241 plus Celebrex significantly increased cell death in breast cancer cells compared to either montherapy alone (p<0.05) and led to apoptosis and cell cycle...